Every SEC Form 3/4/5 on record for this filer (CIK 1845711) — 5 issuers, 21 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
This filer is an entity, not a person. This reporting owner's name carries a corporate/fund legal form, so it is an ENTITY filing under Section 16 — typically a fund with a board-designation right or a 10% holder — not an individual. Its 'director' rows are the entity's designation right, not a person's board seat.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ENHA | Enhanced Group Inc. | Director | 2026-05-11 → 2026-05-11 | 2 | — |
| ATAI | AtaiBeckley Inc. | 10% owner | 2021-06-17 → 2026-04-10 | 19 | $46M |
| BNOX | BIONOMICS LTD/ADR | 10% owner | 2024-10-07 → 2024-10-07 | 2 | −$82,527 |
| ANRO | Alto Neuroscience, Inc. | Filer · lapsed | 2024-02-02 → 2024-03-06 | 2 | — |
| SNSE | Sensei Biotherapeutics, Inc. | 10% owner · lapsed | 2022-07-20 → 2023-06-02 | 3 | $3,542 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ATAI | 2025-08-14 | Buy | 8,675,799 | $2.19 | $19M | 51,045,214 |
| ATAI | 2025-03-24 | Buy | 1,800,000 | $1.40 | $3M | 42,369,415 |
| ATAI | 2025-02-14 | Buy | 10,835,718 | $2.10 | $23M | 40,555,215 |
| BNOX | 2024-10-04 | Sell | 557 | $0.28 | $156 | 93,369,060 |
| BNOX | 2024-10-03 | Sell | 180,707 | $0.29 | $52,405 | 93,469,320 |
| BNOX | 2024-10-02 | Sell | 90,806 | $0.33 | $29,966 | 125,996,580 |
2 of 5 issuers are covered and open a security page; the rest are on file here only.
